Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Machine learning predicts the growth of cyanobacterial genera in river systems and reveals their different environmental responses.

The Science of the total environment·2024

Same author

The Structure Characteristics of Laminar Premixed Flames of Gasoline-like Fuel Under CI Engine-Relevant Conditions.

ACS omega·2024

Same author

Assessing a respiratory toxic infectious bronchitis virus (IBV) strain: isolation, identification, pathogenicity, and immunological failure insights.

Microbiology spectrum·2024

Same author

PARP-1 dependent cell death pathway (Parthanatos) mediates early brain injury after subarachnoid hemorrhage.

European journal of pharmacology·2024

Same author

Comparative transcriptome analysis reveals transcriptional regulation of anthocyanin biosynthesis in purple radish (Raphanus sativus L.).

BMC genomics·2024

Same author

The influence of the doping concentration and reverse intersystem crossing on the efficiency of tricomponent organic light-emitting diodes with the thermally activated delayed fluorescence exciplex emitter.

RSC advances·2024

Search research articles

Related Experiment Video

Updated: Jun 26, 2025

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Advances in proteomics in diffuse large B‑cell lymphoma (Review).

Zihan Guo¹, Chenchen Wang¹, Xinyi Shi¹

¹Department of Hematology and Oncology, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.

Oncology Reports

|May 17, 2024

Summary

Proteomics offers new insights into diffuse large B-cell lymphoma (DLBCL) by identifying molecular mechanisms and drug resistance. This approach aids in developing targeted therapies and improving prognostic evaluations for DLBCL patients.

Keywords:

diagnosis diffuse large B‑cell lymphoma drug resistance multi‑omics prognosis proteomics treatment tumor microenvironment

More Related Videos

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Related Experiment Videos

Last Updated: Jun 26, 2025

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Area of Science:

Oncology
Proteomics
Molecular Biology

Background:

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin's lymphoma.
Despite advances, approximately 40% of DLBCL patients remain uncured with first-line treatment.
Mechanisms of drug resistance and poor prognosis in DLBCL are not fully understood.

Purpose of the Study:

To review the application of proteomic methods in DLBCL research.
To investigate DLBCL disease progression and drug resistance mechanisms using proteomics.
To explore the role of the tumor microenvironment in lymphoma growth via proteomic analysis.

Main Methods:

Proteomics to identify protein expression changes in DLBCL.
Monitoring protein level alterations during disease development.
Analyzing proteomic data for molecular mechanism discovery.

Main Results:

Proteomics can reveal associations between protein expression and DLBCL stages.
Proteomic studies may uncover novel molecular and drug resistance mechanisms.
Identification of potential therapeutic targets and prognostic markers in DLBCL.

Conclusions:

Proteomics holds significant potential for advancing DLBCL understanding and treatment.
Proteomic-guided strategies can improve therapeutic outcomes and prognostic accuracy.
Proteomic methods offer synergistic benefits for DLBCL research and clinical applications.